Botulinum therapy for chronic migraine.
Article
in English
| IMSEAR
| ID: sea-136456
ABSTRACT
Chronic migraine (CM) is an important cause of chronic daily headache (CDH), a common severe headache syndrome. Patients with CM are significantly disabled from employment and overuse pain relieving medications. CM is a difficult condition to treat. Overuse of abortive medications and limited benefit from oral preventive medications are an important problem in managing this condition. Recent randomized controlled trials evaluating the efficacy of botulinum toxin A (BoNT-A) have confirmed its efficacy for CM prophylaxis. BoNT-A is a safe drug with no systemic reactions in clinical trials for headache.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Type of study:
Controlled clinical trial
Language:
English
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS